Summit, AstraZeneca Discuss $15 Billion Cancer Drug Deal
Summit Therapeutics conducts advanced talks with AstraZeneca about a possible partnership worth up to $15 billion according to sources who ...
Read moreDetails
© 2025 Newsweek U.S. All rights reserved.
